Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Our growth depends on the superior equipment ,exceptional talents and continuously strengthened technology forces for CAS 753498-25-8, 3-Chloro-245-trifluorobenzoic Acid, Remdesivir Intermediate, If needed, welcome to help make speak to with us by our web page or cellular phone consultation, we are going to be delighted to serve you.

Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu Detail:

Commercial Supply Molnupiravir and Related Intermediates with High Quality
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4

Chemical Name	Molnupiravir N-1
Synonyms	((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate; Molnupiravir Intermediate; Molnupiravir Dimethyl Dioxol Impurity; Molnupiravir Impurity 11
CAS Number	2346620-55-9
CAT Number	RF-PI310
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C16H23N3O7
Molecular Weight	369.37
Solubility	Soluble in DMSO
Density	1.51±0.1 g/cm3
Shipping Temperature	Ambient
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Loss on Drying	≤1.0%
Residue on Ignition	≤0.20%
Single Impurity	≤0.50%
Total Impurities	≤2.0%
Heavy Metals	≤20ppm
Purity	≥98.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Molnupiravir (CAS 2349386-89-4) COVID-19

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Molnupiravir N-1 (CAS 2346620-55-9), is the intermediate of Molnupiravir (CAS 2349386-89-4) in treatment of COVID-19. Molnupiravir (EIDD-2801) is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 (7 mg/kg; p.o.; twice daily for 3.5 days) significantly reduces shed virus load and duration of fever. Molnupiravir (EIDD-2801) is efficiently hydrolyzed in vivo after absorption, resulting in detection of only free NHC in plasma. EIDD-2801 robustly reduces MERS-CoV infectious titers, viral RNA, and pathogenesis under both prophylactic and early therapeutic conditions. Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19.

Product detail pictures:

Related Product Guide:

To be the stage of realizing dreams of our employees! To build a happier, far more united and far more specialist team! To reach a mutual profit of our customers, suppliers, the society and ourselves for Fast delivery D-Glucuronic Acid Lactone - Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality – Ruifu , The product will supply to all over the world, such as: Mexico, Slovak Republic, Senegal, we are sincerely hope to establish one good long term business relationship with your esteemed company thought this opportunity, based on equal, mutual beneficial and win win business from now till the future.